Skip to main content
Caplin Point Laboratories Ltd. logo

Caplin Point Laboratories Ltd. — Investor Relations & Filings

Ticker · CAPLIPOINT ISIN · INE475E01026 LEI · 33580043U3LXMROY5J69 BSE.NS Manufacturing
Open in API
Filings indexed 705 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country IN India
Listing BSE.NS CAPLIPOINT

About Caplin Point Laboratories Ltd.

https://www.caplinpoint.net

Caplin Point Laboratories Ltd. is a pharmaceutical organization focused on the development, manufacturing, and marketing of finished dosage forms. Its extensive product portfolio encompasses tablets, capsules, injections, liquid orals, and softgel capsules across diverse therapeutic categories. The company utilizes a vertically integrated business model, overseeing the complete value chain from research and development to final distribution. Caplin Point maintains a significant market presence in Latin America and Francophone Africa, supported by a specialized end-to-end logistics and supply chain network. Furthermore, through its subsidiary Caplin Steriles, the company has established a footprint in regulated markets, specializing in sterile injectables and ophthalmic products. Its manufacturing infrastructure is designed to meet global regulatory requirements, including certifications from the US FDA and EU GMP.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notifying stock exchanges of the company’s participation in an upcoming Analyst/Institutional Investors Meeting. It does not contain financial statements, earnings data, presentation content, or vote results, but is a compliance filing announcing a corporate event. This falls under general regulatory announcements for SEBI compliance, so it is classified as Regulatory Filings (RNS).
2026-05-22 English
Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 75% confidence The document is a regulatory intimation under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing stock exchanges of the company’s participation in an analyst/institutional investors meeting. It contains no financial statements or substantive financial data, nor is it the text of a presentation or transcript. This falls under a general regulatory announcement that does not fit more specific categories, so it is classified as a Regulatory Filing (RNS).
2026-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement Classification · 92% confidence The document is a letter to stock exchanges under SEBI LODR announcing that the transcript of the Q4 FY2025–26 earnings call is now available on the company’s website. It does not contain the actual transcript or financial data but simply announces the publication of the report.
2026-05-21 English
Transcript for Earnings call- Q4- FY 2025-26
Report Publication Announcement Classification · 90% confidence The document is a short letter to stock exchanges notifying them that the earnings call transcript is now available on the company’s website. It does not contain the transcript itself or substantive financial data, but rather announces publication of the report. Under the “menu vs meal” rule, this is a report publication announcement. Therefore, it should be classified as RPA.
2026-05-21 English
Earnings call for Q4(2025-26)
Report Publication Announcement Classification · 85% confidence The document is a short notice to stock exchanges that the audio recording of the Q4/FY2025-26 earnings call has been made available on the company website. It does not contain the earnings data itself, nor the transcript, but simply announces the publication of the recording. Under the “Menu vs Meal” rule, this is an announcement of report availability rather than a full report or transcript. Therefore, it fits “Report Publication Announcement” (RPA).
2026-05-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement Classification · 85% confidence The document is a short corporate announcement to stock exchanges informing investors that the audio recording of the Q4 FY2025-26 earnings call has been made available on the company website. It contains no financial statements or substantive data, and simply notifies about the publication of an audio report rather than delivering the report itself. Under our definitions, this is a Report Publication Announcement (RPA).
2026-05-14 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.